secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-06-02T12:30:28+00:00
Accession:  0001493152-26-026773
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity SAB webinar on CyPath Lung for early lung cancer detection on June 16
--------------------------------------------------------------------------------

- Society for Advanced Bronchoscopy hosts free webinar June 16, 7pm ET on CyPath Lung's role in early lung cancer detection.
- Panel includes med onc Vijay Gunuganti, thoracic surgeon Reginald Baptiste, interventional pulmonologist Sai Guda.
- CyPath Lung is a noninvasive sputum test using flow cytometry and AI; published trial: 92% sensitivity, 87% specificity, 99% NPV for nodules <20mm.
- Webinar to discuss real-world benefits: guiding surgery, reducing unnecessary procedures, supporting surveillance.
- CEO Maria Zannes notes collaboration with SAB to advance minimally invasive lung diagnostics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226026773/0001493152-26-026773-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226026773/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-026773

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer